Nicox Provides Fourth Quarter 2021 Business and Financial Highlights
Press ReleaseNicox Provides Fourth Quarter 2021 Business and Financial HighlightsMont Blanc Phase 3 clinical trial of NCX 470 in glaucoma...
Month: January 2022
iCRYO Partners With 24 Hour Fitness
Fitness Industry Giant And Recovery Leader Come Together To Provide Full Body Wellness To 24 Hour Fitness Members HOUSTON, TEXAS,...
Clover’s Final SPECTRA Phase 2/3 Clinical Trial Efficacy Data Is Published in The Lancet
CHENGDU, China, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global clinical-stage biotechnology company developing...
Extendicare Announces Timing of 2021 Fourth Quarter Results and Year End Results and Conference Call
MARKHAM, Ontario, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it...
Opiant Pharmaceuticals Announces First Patient Dosed in Phase 2 Trial of OPNT002, Nasal Naltrexone, for Alcohol Use Disorder
Phase 2 trial to evaluate reduction in heavy drinking as measured by a change in the World Health Organization drinking...
Correction: Opiant Pharmaceuticals Corrects Error in Issuing Duplicate Press Release Today
SANTA MONICA, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Correction: Opiant Pharmaceuticals, Inc. (“Opiant” or “Company”) (NASDAQ: OPNT), a specialty...
Kraig Biocraft Laboratories Closes Additional Funding Agreement
Robust financial strength positions Company to deploy Impact CapitalANN ARBOR, Mich., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories,...
Bioasis Announces Filing of Its Quarter and Financial Statements and MD&A for the Period Ending November 30, 2021
NEW HAVEN, Conn., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Bioasis Technologies Inc. (TSX.V:BTI; OTCQB:BIOAF) (the “Company” or “Bioasis”), a biopharmaceutical company...
Circulating Tumor Cell (CTC) Isolation with TellDx Technology Could Inform Personalized Drug Treatment in Prostate Cancer
-- Single-cell proteomics can elucidate kinase activity in prostate cancer models -- -- Kinase activity in bone metastases and epithelial...
Rapid Micro Biosystems Appoints Michael Beaulieu as Vice President, Investor Relations and Corporate Communications
LOWELL, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences...
Conformis, Inc. to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 2, 2022
BILLERICA, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that as mentioned on its Business...
Oncternal Therapeutics Hosting Key Opinion Leader Webinar on Hematological Malignancies and Prostate Cancer
Session will include a discussion of the treatment landscape for Mantle Cell Lymphoma, including potential role of Zilovertamab, Oncternal’s ROR1...
ASLAN Pharmaceuticals Initiates Phase 2b Study of ASLAN004 (Eblasakimab) in Moderate-to-Severe Atopic Dermatitis
The TRials with EblasaKimab in Atopic Dermatitis (TREK-AD) study will evaluate the efficacy and safety of ASLAN004, now known as...
Intuitive Announces Fourth Quarter Earnings
SUNNYVALE, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive...
Daxor Corporation to Commence Trading on The Nasdaq Capital Market On February 2, 2022
Oak Ridge, TN, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement...
Maravai LifeSciences Announces Debt Repricing
Lowers Interest Rates on Current Debt to Provide Approximately $6.8 Million in Annual Interest SavingsSAN DIEGO, Jan. 20, 2022 (GLOBE...
Kura Oncology Receives FDA Authorization to Proceed with Phase 1b Study of KO-539 in Acute Myeloid Leukemia
– FDA lifts partial clinical hold following agreement on mitigation strategy for differentiation syndrome – – KOMET-001 study to resume...
Eargo Applauds Proposed Rule for OTC Hearing Aids and Submits Public Comments to FDA
SAN JOSE, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission...
Inventiva announces participation at several conferences in January and February 2022
Daix (France), Long Island City (New York, United States), January 20, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA), a...
EssilorLuxottica : EssilorLuxottica appoints new member to its Board of Directors
EssilorLuxottica appoints new member to its Board of Directors As the new Valoptec Association President, Virginie Mercier Pitre replaces Juliette...
